Growth Metrics

Novartis Ag (NVS) Change in Intangibles (2009 - 2026)

Novartis Ag recorded quarterly Change in Intangibles of -$461.0 million in Q1 2026, down 12.99% quarter-over-quarter from -$408.0 million in Q4 2025.

Novartis Ag's Change in Intangibles history runs 12 years deep, the most recent figure standing at -$461.0 million for Q1 2026.

  • In Q1 2026, Change in Intangibles changed N/A year-over-year to -$461.0 million; the TTM figure through Mar 2026 stood at -$1.6 billion (changed N/A YoY), while the FY2025 annual figure was $164.0 million, up 105.0% from the prior year.
  • Change in Intangibles came in at -$461.0 million for Q1 2026 at Novartis Ag, down from -$408.0 million in the prior quarter.
  • In the past five years, Change in Intangibles ranged from a high of -$192.0 million in Q4 2022 to a low of -$929.0 million in Q1 2024.
  • A 5-year average of -$442.8 million and a median of -$441.5 million in 2023 frame the typical range for Change in Intangibles.
  • Across the five-year window, Change in Intangibles jumped 63.29% in 2023 and slumped 320.36% in 2024, its largest moves.
  • Novartis Ag's Change in Intangibles stood at -$192.0 million in 2022, then sank by 96.35% to -$377.0 million in 2023, then plunged by 51.99% to -$573.0 million in 2024, then climbed by 28.8% to -$408.0 million in 2025, then slipped by 12.99% to -$461.0 million in 2026.
  • According to Business Quant data, Change in Intangibles over the past three periods registered -$461.0 million, -$408.0 million, and -$477.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Intangibles (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -461.00 Mn
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn -
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn -
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn -
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn -
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn -
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn -
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn -
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn -
10 Gsk 88.34 Bn 83.66 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -461.00 Mn
Mar 31, 2026 -461.00 Mn
Dec 31, 2025 -408.00 Mn
Dec 31, 2025 -408.00 Mn
Sep 30, 2025 -477.00 Mn
Sep 30, 2025 -477.00 Mn
Jun 30, 2025 -227.00 Mn
Jun 30, 2025 -227.00 Mn
Dec 31, 2024 -573.00 Mn
Dec 31, 2024 -573.00 Mn
Sep 30, 2024 -478.00 Mn
Sep 30, 2024 -478.00 Mn
Jun 30, 2024 -468.00 Mn
Jun 30, 2024 -468.00 Mn
Mar 31, 2024 -929.00 Mn
Mar 31, 2024 -929.00 Mn
Dec 31, 2023 -377.00 Mn
Dec 31, 2023 -377.00 Mn
Sep 30, 2023 -422.00 Mn
Sep 30, 2023 -422.00 Mn
Jun 30, 2023 -673.00 Mn
Jun 30, 2023 -673.00 Mn
Mar 31, 2023 -221.00 Mn
Mar 31, 2023 -221.00 Mn
Dec 31, 2022 -192.00 Mn
Dec 31, 2022 -192.00 Mn
Sep 30, 2022 -251.00 Mn
Sep 30, 2022 -251.00 Mn
Jun 30, 2022 -326.00 Mn
Jun 30, 2022 -326.00 Mn
Mar 31, 2022 -602.00 Mn
Mar 31, 2022 -602.00 Mn
Dec 31, 2021 -517.00 Mn
Dec 31, 2021 -517.00 Mn
Sep 30, 2021 -188.00 Mn
Sep 30, 2021 -188.00 Mn
Jun 30, 2021 -276.00 Mn
Jun 30, 2021 -276.00 Mn
Mar 31, 2021 -612.00 Mn
Mar 31, 2021 -612.00 Mn
Dec 31, 2020 -502.00 Mn
Dec 31, 2020 -502.00 Mn
Sep 30, 2020 -348.00 Mn
Sep 30, 2020 -348.00 Mn
Jun 30, 2020 -214.00 Mn
Jun 30, 2020 -214.00 Mn
Mar 31, 2020 -246.00 Mn
Mar 31, 2020 -246.00 Mn
Dec 31, 2019 -175.00 Mn
Dec 31, 2019 -175.00 Mn
Sep 30, 2019 -205.00 Mn
Sep 30, 2019 -205.00 Mn
Jun 30, 2019 -161.00 Mn
Jun 30, 2019 -161.00 Mn
Mar 31, 2019 -337.00 Mn
Mar 31, 2019 -337.00 Mn
Dec 31, 2018 -206.00 Mn
Dec 31, 2018 -206.00 Mn
Sep 30, 2018 -546.00 Mn
Sep 30, 2018 -546.00 Mn
Jun 30, 2018 -226.00 Mn
Jun 30, 2018 -226.00 Mn
Mar 31, 2018 -416.00 Mn
Mar 31, 2018 -416.00 Mn
Dec 31, 2017 -332.00 Mn
Dec 31, 2017 -332.00 Mn
Sep 30, 2017 -287.00 Mn
Sep 30, 2017 -287.00 Mn
Jun 30, 2017 -221.00 Mn
Jun 30, 2017 -221.00 Mn
Mar 31, 2017 -210.00 Mn
Mar 31, 2017 -210.00 Mn
Dec 31, 2016 -195.00 Mn
Dec 31, 2016 -195.00 Mn
Sep 30, 2016 -478.00 Mn
Sep 30, 2016 -478.00 Mn
Dec 31, 2009 -846.00 Mn
Dec 31, 2009 -846.00 Mn